Friday, July 24, 2026
Advertisement
Home Healthcare Markets News Bupa and Spire expand oncology and MSK pathways as part of new...

Bupa and Spire expand oncology and MSK pathways as part of new four-year deal

Bupa UK insurance and Spire Healthcare have announced plans to expand oncology and musculoskeletal (MSK) patient pathways as part of a new four-year strategic partnership agreement. The agreement builds on the longstanding relationship between the UK’s largest PMI provider and hospital group, which includes access to eight existing cancer specialist centres across the UK. Under…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?